Neurology® Podcast

American Academy of Neurology
undefined
Jun 16, 2022 • 22min

Medicare Limitation of Aduhelm

Dr. Jeff Burns talks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Research Center, about Medicare's recent decision to officially limit Aduhelm (aducanumab) coverage to patients in clinical trials. Read the full article discussed in this interview in the New York Times.
undefined
Jun 13, 2022 • 11min

EEG Patterns and Neurofilament Light After Cardiac Arrest

Dr. Karen Hirsch talks with Dr. Linnéa Grindegård about the association between EEG patterns and serum neurofilament light as a marker of neuroaxonal injury after cardiac arrest. Read the full article in Neurology. 
undefined
Jun 9, 2022 • 14min

Race-Ethnic Disparities in Stroke Thrombolysis

Drs. B.J. Hicks and Andy Southerland talk with Dr. Scott Mendelson about racial and ethnic disparities in the rates of declination of thrombolysis in patients with acute ischemic stroke. Read the full article in Neurology.
undefined
Jun 6, 2022 • 22min

A Review of L-arginine in MELAS

Dr. Justin Abbatemarco talks with Prof. Gráinne Gorman about the use of L-arginine in the treatment of mitochondrial encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Read the full article in Neurology. 
undefined
Jun 2, 2022 • 15min

Pure Sleep Epilepsy in Patients With First Seizure

Dr. Fábio Nascimento talks with Dr. Elaine Pang about the identification and characterization of pure sleep epilepsy after first-ever seizures from sleep in adults. Read the full article in Neurology. 
undefined
Jun 1, 2022 • 1h 6min

June 2022 Neurology Recall: Aducanumab's Approval, One Year Later

The June 2022 replay of past episodes showcases a selection of interviews about the impact of the FDA's approval of aducanumab for the treatment of Alzheimer disease (AD). This episode features illuminating conversations with Drs. Gregg Day, Ron Petersen, and Jason Karlawish on the clinical science guiding amyloid-based treatments for AD, the importance of patient participation when considering the use of aducanumab, and the business of Alzheimer disease, respectively. This month's Recall concludes with an interview featuring Pulitzer Prize-winning journalist Pam Belluck on Medicare's limitations on aducanumab coverage.
undefined
May 31, 2022 • 13min

Association of PD Symptoms With Quality of Life

Dr. Jeff Ratliff talks with Dr. Meredith Bock about the association of motor, non-motor, and behavioral symptoms with health-related quality of life in people with Parkinson disease. Read the full article in Neurology.
undefined
May 26, 2022 • 19min

Neurodegeneration in Pro Football Players: TBI/CTE

In the second part of our two-part series on neurodegeneration in professional football players, Dr. Shuvro Roy talks with Dr. Ann McKee about her career and work studying the consequences of repetitive traumatic brain injury (TBI) and chronic traumatic encephalopathy (CTE). For more information on the VA-BU-CLF Brain Bank at the Boston University CTE Center, including brain donation inquiries, click here.
undefined
May 23, 2022 • 19min

Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia in Children

Dr. Justin Abbatemarco talks with Dr. Ming Lim about the diagnosis and management of opsoclonus myoclonus ataxia syndrome (OMAS) in children. Read the full article in Neurology: Neuroimmunology & Neuroinflammation.
undefined
May 19, 2022 • 14min

Neurodegeneration in Pro Football Players: ALS

In the first part of our two-part series on neurodegeneration in professional football players, Dr. Shuvro Roy talks with Dr. Ann McKee about the high incidence and mortality rates of amyotrophic lateral sclerosis (ALS) in NFL athletes. For more information on the VA-BU-CLF Brain Bank at the Boston University CTE Center, including brain donation inquiries, click here.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app